Feasibility of Docetaxel-cisplatin as 3rd or 4th line treatment for recurrent or unresectable biliary tract cacner.
Not Applicable
Recruiting
- Conditions
- Biliary tract cancer
- Registration Number
- JPRN-UMIN000009212
- Lead Sponsor
- yokohama city university graduated school of medicine Department of Gastroenterological Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
If patients reject.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to progression
- Secondary Outcome Measures
Name Time Method